Ipamorelin

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) in the growth-hormone secretagogue class. First developed in the 1990s by Novo Nordisk, it was initially investigated for growth-hormone deficiency and related conditions. Unlike GHRP-6 or GHRP-2, ipamorelin does not substantially increase ghrelin activity, nor cause significant elevations in cortisol, aldosterone, or prolactin at therapeutic doses.Reported areas of research interest:Stimulation of natural growth-hormone releaseEnhanced lipolysis and fat metabolismImproved muscle protein synthesis and recoveryIncreased bone mineral densityCollagen production for skin and joint healthImproved sleep architecture and qualitySpecification: 10 mg per vial · 99%+ purity · lyophilized powder · for laboratory and research use only. Not for human or veterinary use.

• Supplied as a lyophilized powder for laboratory reconstitution.
• HPLC purity and mass-spec identity verified on every lot.
• Backed by a lot-specific Certificate of Analysis.
• Strictly for in-vitro research use only.

Reconstitute with bacteriostatic or sterile water as appropriate for your protocol. Store reconstituted material refrigerated and use within the timeframe indicated by your research procedures.